Send us Fan Mail

The FDA is facing a deadline next week to publish three federal cannabinoid lists and to clarify what counts as a hemp product “container” under appropriations legislation President Donald Trump signed last year. Those lists and the “container” guidance are due by Tuesday, and they matter because the law is scheduled to change federal hemp rules in November—shifting from a delta-9 THC standard to “total THC” (including delta-8 and other isomers) and potentially restricting a wide range of consumable cannabinoid products.

00:00 Welcome and Episode Overview
00:59 Super Bowl Sunday Vibes
01:36 FDA's Upcoming Deadline on Hemp Definitions
03:38 Hemp Industry and Legal Confusion
08:43 Cannabis and Hemp Policy Roundtable
12:53 New Member Shoutouts and Upcoming Content
13:54 Legal Challenges and Market Dynamics
26:29 Dispensary Tour and Regulations
28:04 State Security Regulations
28:41 Building Renovations and Compliance
29:08 Cannabis Legalization and Regulations
29:46 Logo Contest and Compliance Challenges
31:05 Federal Security Clearances and Cannabis
32:09 Cannabis and Holistic Wellness
32:54 Cannabis Industry and Legalization Challenges
40:50 Minnesota Cannabis Raid and Legal Battle
42:04 Cannabis Strain Review
45:28 Oklahoma's Black Market Crackdown
50:58 Ohio's Antitrust Lawsuit Against MSOs
55:31 Final Thoughts on Cannabis Policy
#CannabisNews #Hemp #FDA #THC #CBD #Delta8 #FarmBill #Cannabinoids #CannabisLegalization

want to start your own podcast?  Try StreamYard.
Want to create live streams like this? Check out StreamYard: https://streamyard.com/pal/d/5822037327085568

Support the show

Get our newsletter: https://bit.ly/3VEn9vu

Send us Fan Mail

📰 Free Newsletter – https://bit.ly/3VEn9vu
🧢 CLN Merch
https://spreadshop-admin.spreadshirt....
🤝 Work With Us
https://bit.ly/m/collateral-base
👍 Like • 🔔 Subscribe • 💬 Comment:

In this educational video, attorney Tom Howard discusses the pivotal Supreme Court case of US v Hemani, which addresses the legality of cannabis users possessing firearms. Starting with background information, Tom covers the specific statute in question, 18 USC 922(g)(3), and its impact on cannabis users. He highlights the procedural history, the current circuit split, and the constitutional tests involved. Tom emphasizes the potential overreach of Congressional law and examines the historical traditions of firearm regulation. The video also delves into related legal considerations and potential outcomes of the case, with oral arguments set for March 2nd. Stay informed, subscribe for more updates, and join the discussion on cannabis legalization and Second Amendment rights.

00:00 Introduction to the Case
00:34 Understanding US v Hemani
00:52 Legal Background and Statutes
01:27 Procedural History and Supreme Court Involvement
02:17 Constitutional and Historical Context
03:11 Implications for Cannabis Users
05:11 Comparisons with Other Substances and Cases
07:53 Policy and Government Actions
09:34 Conclusion and Final Thoughts

Support the show

Get our newsletter: https://bit.ly/3VEn9vu

Send us Fan Mail

In this episode, the hosts discuss the current state of cannabis legalization, focusing on its gradual normalization rather than sweeping legislative changes. Key topics include the NRA's alignment with cannabis advocates in a Supreme Court case, the proliferation of hemp THC drinks, and the emergence of city-run dispensaries. The hosts also touch on the evolution of laws regarding cannabis users' Second Amendment rights and the impact of research on cannabis legalization. Highlights also cover regulatory challenges faced by the hemp industry and updates from various states on cannabis policies, including Alabama's controversial bill on cannabis odor and child welfare, and Florida's ongoing legal battles over marijuana possession.

00:00 Introduction to Cannabis Legalization and Normalization
01:12 NRA and Cannabis Advocates Unite
02:27 Cannabis and Firearm Rights Debate
04:59 Opioids and Cannabis: A New Perspective
06:09 Hemp THC Drinks and Market Dynamics
09:11 Challenges in Cannabis Legislation and Market
17:02 Federal Regulations and Hemp Production
19:25 Licensing and Regulation Challenges
21:23 CBD Regulation and Market Dynamics
22:42 State-Specific Cannabis Legislation
24:44 Municipal Control and Market Impact
27:04 Legal and Social Implications
30:02 Industry Trends and Future Outlook
37:43 Concluding Thoughts and Announcements

Support the show

Get our newsletter: https://bit.ly/3VEn9vu

Send us Fan Mail

Navigating the Legal Maze of Schedule Three Cannabis Rescheduling

In this special episode of Cannabis Legalization News, the intricate process of moving cannabis to Schedule Three is thoroughly examined. The host breaks down the involved statutes, rules, and legal procedures, including key milestones such as interlocutory appeals, DEA hearings, and the final rescheduling rule. The episode highlights the delays and legal hurdles over recent years, explaining the role of administrative law judges, public comments, and the potential impact of the Congressional Review Act (CRA). The timeline for when cannabis might actually be rescheduled to Schedule Three under federal law is discussed, ranging from late 2026 to potentially 2028, depending on procedural and legal challenges.

00:00 Introduction and Overview
00:06 Current Status of Schedule Three Cannabis
02:03 Legal Procedures and Statutes
03:28 Steps to Reschedule Cannabis
04:30 Interlocutory Appeal and Hearing
06:45 Post-Hearing Procedures
09:49 Congressional Review Act (CRA)
11:47 Judicial Review and Final Thoughts
13:40 Conclusion and Viewer Interaction

Support the show

Get our newsletter: https://bit.ly/3VEn9vu

Send us Fan Mail

Welcome to Cannabis Legalization News, where we discuss the latest developments in the cannabis industry. This week, we cover why hemp did not receive an extension despite the averted government shutdown, a key topic often debated in the context of the farm bill. We also dive into state-specific news from Virginia, Montana, and Missouri, and address the ongoing discussions around thc and cbd regulations. 👍 Like • 🔔 Subscribe • 💬 Comment: What’s the REAL endgame for hemp—regulation, carveouts, or a quiet ban?

SOURCES & LINKS MENTIONED:
MJBizDaily (CBD/Medicaid coverage in limbo) – https://mjbizdaily.com/news/medicaid-...

Chicago hemp ban (beverages exempted) – https://www.restaurantbusinessonline....

Cascadia Daily News (UW workplace hazards) – https://www.cascadiadaily.com/2026/ja...

Nebraska medical cannabis law (Howard Law Group) – https://cannabisindustrylawyer.com/ne...

Name That Strain – https://humboldtseedcompany.com/chick...

🎧 Review the podcast on Apple:
https://podcasts.apple.com/us/podcast...

Support the show

Get our newsletter: https://bit.ly/3VEn9vu

Send us Fan Mail

In this episode of Cannabis Legalization News, host Tom updates viewers on the latest developments in federal cannabis policy, focusing on federal law, administrative choices, and the potential rescheduling of cannabis. The episode features a conversation with a new member, Joshua Potter, and a deep dive into consumer preferences for THC and CBD ratios in cannabis beverages. 

Tom also discusses the evolving landscape of legal cannabis in the U.S. and the international market's potential impact on legalization. Special guest Aaron Zeman joins from Hawaii to discuss his experiences with activism, legal battles, and the unique challenges of growing cannabis in Hawaii. The show concludes with a segment about the upcoming Hawaii Cannabis Expo and a fun 'Name That Strain' game featuring Relief Botanical's Humboldt Dream.

00:00 Introduction and Weekly Overview
00:26 Federal Law and Policy Changes
01:12 Cannabis Beverage Market Discussion
02:50 Rescheduling and Legalization Challenges
12:59 Guest Interview: Activism and Legal Battles
15:10 Supreme Court and Legal Precedents
26:21 International Cannabis Market
37:17 Compliance and Regulation in the Cannabis Industry
40:58 Supreme Court and Firearms Case
41:17 Legal Perspectives on Firearms and Cannabis
42:07 Dormant Commerce Clause and Marijuana Commerce
44:09 Regulatory Load in the Cannabis Industry
46:16 Hawaii Cannabis Expo and Book Signing
47:15 Challenges in the Cannabis Industry
59:24 Cannabis Industry vs. Cannabis Plant
01:02:07 Cannabis Legalization and Market Dynamics
01:09:54 Hawaiian Cannabis Strains and Cultivation
01:13:50 Closing Remarks and Future Prospects

Support the show

Get our newsletter: https://bit.ly/3VEn9vu

Send us Fan Mail

Cannabis Legalization News 2026: Key Predictions, Rescheduling Updates, and Industry Insights

In this episode of Cannabis Legalization News, the hosts dive into the latest developments and predictions for cannabis legalization in 2026. They discuss an unexpected geopolitical event involving the extraction of the Venezuelan president by the U.S., which may delay the rescheduling of marijuana to Schedule III. The episode covers various federal and state-level updates, including changes in hemp regulations, the implications of rescheduling for businesses and consumers, and predictions for the timeline of these changes. Other topics include the challenges faced by dispensaries due to stringent regulations, the economic impact on hemp farmers, and the evolving legal landscape. Engaging with listener questions, the hosts also touch upon the potential benefits of rescheduling for veterans and medical use, as well as the importance of comprehensive legalization reforms.

00:00 Introduction to 2026 Cannabis Legalization News
00:29 Unexpected Political Developments
00:43 Impact on Cannabis Rescheduling
01:21 Predictions for Cannabis Legalization in 2026
03:47 Discussion on Hemp Redefinition
08:59 Challenges in Cannabis Business Financing
12:14 THC and Hemp Industry Dynamics
13:59 Federal and State Legal Challenges
16:08 Rescheduling and Its Implications
17:40 Veterans and Cannabis: A New Hope
32:12 Introduction to the New Format
32:27 Medical Marijuana and Strain Preferences
33:07 Challenges with Legalization and Compliance
34:21 The Frustrations of Legalization Efforts
36:01 Cannabis Legalization News
37:19 The Legal Process and Bureaucratic Hurdles
38:54 Federal vs. State Regulations
41:04 The Impact of Rescheduling on the Industry
45:21 State-Level Marijuana Reforms
01:00:58 Conclusion and Future Outlook

Support the show

Get our newsletter: https://bit.ly/3VEn9vu

Send us Fan Mail

In this episode of Cannabis Legalization News, Tom, a cannabis lawyer, discusses his key predictions for cannabis and hemp legalization in 2026. He outlines three major points: the anticipated rescheduling of marijuana to Schedule 3 and its financial implications for the industry, the potential shutdown of the current hemp market due to new federal definitions and enforcement, and the long-term impact of enhanced research on cannabinoids for medical use. Tom also delves into the timeline for these changes, explaining how actions from Congress, the DOJ, and the FDA will shape the future of cannabis legislation.

00:00 Introduction and 2026 Predictions Overview
00:28 Understanding Schedule Three and 280E
00:50 Debunking Common Misconceptions
01:37 Rescheduling Timeline and Industry Impact
02:43 Hemp Legislation and Enforcement
03:37 Congressional Actions and Deadlines
04:35 FDA's Role and New Hemp Definitions
06:51 Executive Orders and Regulatory Framework
12:58 Research and Medical Use of Cannabinoids
15:12 Predictions for 2026
16:34 Conclusion and Call to Action

Support the show

Get our newsletter: https://bit.ly/3VEn9vu

Send us Fan Mail

In this eye-opening episode, we dive into one of America's biggest policy failures: the pricing of prescription medications like GLP-1s. While many focus on the legalization and rescheduling of cannabis, there's a far more insidious, legal, and mainstream drug policy draining your paycheck and costing countless lives. We break down the economics, the hidden players like PBMs, and the stark differences in drug pricing between the US and other countries. Learn how we can fix this broken system and why it matters for your wallet and your health. 💊💸 #DrugPolicy #HealthcareCosts #Cannabis #DrugPrices #GLP1 #EconomicImpact 🌿💰

00:00 Introduction: The Real Worst Drug Policy in America
01:23 Cannabis: The Obvious Candidate
04:30 The Hidden Cost of GLP-1 Medications
06:30 The Economics of GLP-1 Pricing
08:15 Global Comparison and Policy Solutions
14:01 Conclusion: The Real Crime in Drug Policy

In this eye-opening episode, we discuss a mainstream, legal drug policy that is quietly draining more money from your paycheck than the war on drugs. We break down the economics and the hidden players like pharmacy benefit managers (PBMs) that impact your "prescription benefits". Learn how this system impacts your wallet and how to make money moves to protect yourself from these rising "prescription" costs through understanding the role of your "pharmacy" and big "pharmacy benefit manager" companies.

Support the show

Get our newsletter: https://bit.ly/3VEn9vu

Send us Fan Mail

Cannabis Legalization: Industry Updates and Future Projections

In this episode of Cannabis Legalization News, the hosts discuss an array of topics impacting the cannabis industry. They highlight a significant recent executive order from Donald Trump aimed at reclassifying marijuana as a Schedule III drug. The discussion covers the potential impacts of this reclassification on the cannabis industry, including changes in regulation, the importance of API integration in point-of-sale systems, and the ongoing battle against synthetic cannabinoids sourced from China. The show features Kyle Sherman of Flowhub, who shares his journey in cannabis tech, his efforts in compliance solutions, and the industry's evolution. They also discuss the potential improvement in state regulations and examples of successful dispensary operations. The episode concludes with plans for the upcoming Pekin local dispensary and thoughts on the future of cannabis legalization in the United States.

🎙️ SUPPORT THE SHOW

📩 Get our free newsletter (spicy & actually useful):
https://bit.ly/3VEn9vu

⭐ Leave a review on Apple Podcasts:
https://podcasts.apple.com/us/podcast...

🤝 Sponsor the show or partner with CLN:
https://cannabislegalizationnews.com/...

👩‍⚖️ Need cannabis lawyers in IL, MO, NY, OH, or MI?
https://cannabisindustrylawyer.com

Folks, this was a whiplash week for cannabis law.

The U.S. Supreme Court just refused to hear a case that could have blown up federal marijuana prohibition — leaving state-legal cannabis businesses stuck under a federal ban that everyone admits makes no sense anymore.

And then…
BOOM.

President Trump signed an executive order that does what the Court wouldn’t:
➡️ Orders marijuana’s move to Schedule III
➡️ Acknowledges cannabis has accepted medical use
➡️ Forces the federal government to finally catch up with reality

In this episode of Cannabis Legalization News, we break down exactly what happened — and why this moment matters more than most people realize.

🧠 WHAT WE COVER IN THIS EPISODE:

🌿 Supreme Court Rejects Cannabis Challenge
Why SCOTUS refused to revisit Gonzales v. Raich — and why that keeps legalization stuck in Congress, not the courts.

🧪 Synthetic Cannabinoids Flooding Smoke Shops
A lawsuit exposes how chemically-engineered intoxicants — many allegedly sourced from China — are being sold as “hemp” under the

Support the show

Get our newsletter: https://bit.ly/3VEn9vu